Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
S86 What Does Bowel Urgency Mean? Limitations of a Binary Question to Assess Bowel UrgencyThe American journal of gastroenterology, 2022-12, Vol.117 (12S), p.S22-S22 [Peer Reviewed Journal]2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000897852.87537.deFull text available |
|
2 |
Material Type: Article
|
A22 HEALTH SERVICES HIGHLIGHTS IN CRITICAL CARE: Perceptions Of Data Quality And Accuracy During Icu RoundAmerican journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970Full text available |
|
3 |
Material Type: Article
|
EPV083/#547 Locally advanced cervical carcinoma (LACC) submitted to chemioradiation followed by surgery: a propensity score analysis of response and survival according to histotypeInternational journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A62-A62 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-IGCS.151Full text available |
|
4 |
Material Type: Article
|
494 Maintenance olaparib in platinum-sensitive recurrent ovarian cancer: a comprehensive cancer centre’s experienceInternational journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A241-A241 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.414Full text available |
|
5 |
Material Type: Article
|
791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter databaseInternational journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A123-A124 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.197Full text available |
|
6 |
Material Type: Article
|
Intensifying neoadjuvant treatment in locally advanced rectal cancer – Authors' replyThe lancet oncology, 2021-07, Vol.22 (7), p.e302-e302 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00340-5Full text available |
|
7 |
Material Type: Article
|
0551 Therapeutic Positive Airway Pressure Level Predicts Response to Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaSleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A220-A220 [Peer Reviewed Journal]Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsz067.549Full text available |
|
8 |
Material Type: Article
|
182 Real world experience of pembrolizumab monotherapy in patients with recurrent or persistent cervical cancer: a Korean multi-center retrospective study(KGOG1041)International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A79-A79 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.158Full text available |
|
9 |
Material Type: Conference Proceeding
|
177 Camrelizumab combined with apatinib for refractory gestational trophoblastic neoplasia: A phase 2, single-arm, prospective StudyInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 3), p.A76-A77 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.154Full text available |
|
10 |
Material Type: Article
|
Small Bowel Innate Immune Activation Predicts Clinical Response to Vedolizumab Therapy in Crohn’s DiseaseThe American journal of gastroenterology, 2018-10, Vol.113, p.S327-S327 [Peer Reviewed Journal]Copyright Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins Oct 2018 ;ISSN: 0002-9270 ;EISSN: 1572-0241Full text available |
|
11 |
Material Type: Article
|
Una Exploración de las Propiedades Espaciales Desde la Lógica de los Programas de EstímuloPsykhe, 2020-01, Vol.29 (2) [Peer Reviewed Journal]Copyright Pontificia Universidad Católica de Chile 2020 ;ISSN: 0717-0297 ;EISSN: 0718-2228 ;DOI: 10.7764/psykhe.29.2.1548Full text available |
|
12 |
Material Type: Article
|
Pembrolizumab increases response in resectable gastric, gastroesophageal junction cancersHEM/ONC today, 2024-01, Vol.25 (1), p.19-19 [Peer Reviewed Journal]Copyright SLACK INCORPORATED Jan 2024 ;ISSN: 1526-0488Full text available |
|
13 |
Material Type: Article
|
S876 Efficacy of Deucravacitinib, an Oral, Selective, TYK2 Inhibitor, in Patients With Moderately to Severely Active Ulcerative Colitis and Prior Exposure to Biologic Therapy: Subanalysis From the Phase 2 LATTICE-UC StudyThe American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e632-e633 [Peer Reviewed Journal]2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000860144.00221.24Full text available |
|
14 |
Material Type: Article
|
134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension StudyCNS spectrums, 2020-04, Vol.25 (2), p.284-285 [Peer Reviewed Journal]Cambridge University Press 2020 ;ISSN: 1092-8529 ;EISSN: 2165-6509 ;DOI: 10.1017/S1092852920000504 ;PMID: 32331048Full text available |
|
15 |
Material Type: Article
|
Amivantamab plus Chemotherapy for EGFR+ NSCLC After OsimertinibNEJM journal watch. Oncology & hematology, 2023-11Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 2330-0426Full text available |
|
16 |
Material Type: Article
|
Amivantamab plus Chemotherapy: New Standard for EGFR Exon 20–Mutated NSCLCNEJM journal watch. Oncology & hematology, 2023-11Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 2330-0426Full text available |
|
17 |
Material Type: Article
|
P350 What is the optimum method for collecting robust data to understand a nation’s sexual health needs?Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A181 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1368-4973 ;EISSN: 1472-3263 ;DOI: 10.1136/sextrans-2019-sti.457Full text available |
|
18 |
Material Type: Article
|
EP1292 Minimally invasive palliative treatment of vulval cancer: is there a role for electrochemotherapy?International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A650-A650 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-ESGO.1297Full text available |
|
19 |
Material Type: Article
|
321 Maintenance olaparib for BRCA-mutated ovarian cancer (OC) patients in 1st line and platinum-sensitive relapsed (PSR) settings: maximizing treatment opportunitiesInternational journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A133-A133 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-IGCS.321Full text available |
|
20 |
Material Type: Article
|
Adding Methotrexate to Pegloticase for Gout Increases Response Rate Through 52 WeeksHealio Rheumatology, 2023-11, p.30-30Copyright SLACK INCORPORATED Nov 2023 ;ISSN: 2380-6818 ;EISSN: 2380-6834Full text available |